CIP2A and ovarian serous cystadenocarcinoma: For example, KIAA1524 gene is altered (AMP, GAIN) in ~20% of all 491 lung squamous cell carcinoma cases (TCGA, Provisional; TCGA Lung squamous cell carcinoma, containing 491 samples; raw data at the NCI), altered in ~52% of all 574 ovarian serous cystadenocarcinoma cases (TCGA, Provisional; TCGA ovarian serous cystadenocarcinoma, containing 574 samples; raw data at the NCI), and altered in ~36% of all 459 Head and Neck squamous cell carcinoma cases (TCGA, Provisional; TCGA Head and Neck squamous cell carcinoma, containing 459 samples; raw data at the NCI).